Freenome Shows Continued Leadership in Colorectal Cancer Research

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Oct. 25, 2021 /PRNewswire/ -- Freenome, a privately held biotech company, presented new research at the American College of Gastroenterology (ACG) annual meeting that underscores their commitment to improving colorectal cancer (CRC) screening. In two separate presentations, Freenome examines the benefits and...

Click to view original post